Related Experiment Videos
Angiotensin-converting enzyme gene polymorphism in systemic hypertension
Z A Abbud1, A C Wilson, N M Cosgrove
1TONE Clinical Center, Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903-0019, USA.
The American Journal of Cardiology
|May 20, 1998
Summary
The angiotensin-converting enzyme (ACE) deletion/deletion genotype is linked to hypertension. This finding was significant even after adjusting for age, sex, and body mass index in genetic association studies.
Area of Science:
- Genetics
- Cardiovascular Disease Research
- Human Physiology
Background:
- Hypertension is a major global health concern.
- Genetic factors play a role in hypertension development.
- The angiotensin-converting enzyme (ACE) gene is implicated in blood pressure regulation.
Purpose of the Study:
- To investigate the association between the ACE insertion/deletion (I/D) polymorphism and hypertension.
- To determine if the ACE D/D genotype is a risk factor for hypertension.
Main Methods:
- Genotyping for the ACE I/D polymorphism was performed using polymerase chain reaction (PCR).
- The study included 209 hypertensive patients and 100 normotensive controls.
- Statistical analysis adjusted for age, sex, and body mass index.
Main Results:
- A significant association was found between hypertension and the ACE deletion/deletion (D/D) genotype.
- The D/D genotype was more prevalent in hypertensive individuals compared to normotensive controls.
- The association remained significant after adjusting for key demographic and anthropometric factors.
Conclusions:
- The ACE D/D genotype is a potential genetic marker for hypertension.
- This finding contributes to understanding the genetic basis of hypertension.
- Further research may explore ACE genotype-guided hypertension management strategies.